Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma

Carbonic anhydrase (CA, EC 4.2.1.1) IX is regarded as a tumour hypoxia marker and CA inhibitors have been proposed as a new class of antitumor agents, with one such agent in Phase II clinical trials. The expression of some CAs, in particular the isoforms CA IX and CA XII, has been correlated with tu...

Full description

Saved in:
Bibliographic Details
Published in:J Enzyme Inhib Med Chem
Main Authors: Lucarini, Laura, Magnelli, Lucia, Schiavone, Nicola, Crisci, Alfonso, Innocenti, Alessio, Puccetti, Luca, Cianchi, Fabio, Peri, Sara, Supuran, Claudiu T., Papucci, Laura, Masini, Emanuela
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2017
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011953/
https://ncbi.nlm.nih.gov/pubmed/29251173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2017.1411350
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items